Tag Archives: Ben Klieve

National Securities Corp Keeps a Buy Rating on Limoneira Co (LMNR)

National Securities Corp analyst Ben Klieve reiterated a Buy rating on Limoneira Co (LMNR – Research Report) today and set a price target of $30.00. The company’s shares closed last Monday at $19.41. According to TipRanks.com, Klieve is a 3-star

National Securities Corp Remains a Buy on Marrone Bio (MBII)

National Securities Corp analyst Ben Klieve maintained a Buy rating on Marrone Bio (MBII – Research Report) today and set a price target of $2.50. The company’s shares closed last Monday at $1.02, close to its 52-week low of $1.00.

National Securities Corp Sticks to Its Buy Rating for Calyxt (CLXT)

National Securities Corp analyst Ben Klieve reiterated a Buy rating on Calyxt (CLXT – Research Report) today and set a price target of $16.00. The company’s shares closed last Monday at $7.07. According to TipRanks.com, Klieve is a 3-star analyst

National Securities Corp Keeps a Buy Rating on Yield10 Bioscience Inc (YTEN)

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Yield10 Bioscience Inc (YTEN – Research Report). The company’s shares closed last Monday at $0.96. According to TipRanks.com, Klieve is a 4-star analyst with

Marrone Bio (MBII) Gets a Buy Rating from National Securities Corp

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Marrone Bio (MBII – Research Report). The company’s shares closed yesterday at $1.40. According to TipRanks.com, Klieve is a 4-star analyst with an average

AquaBounty Technologies Inc (AQB) Receives a Buy from National Securities Corp

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on AquaBounty Technologies Inc (AQB – Research Report). The company’s shares closed yesterday at $3.17. According to TipRanks.com, Klieve is a 4-star analyst with an